Skip to main content
logo
MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.330
+0.110 (9.02%)
Dec 22, 2025, 4:00 PM EST - Market closed

Company Description

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells.

The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

MAIA Biotechnology, Inc.
MAIA Biotechnology logo
CountryUnited States
Founded2018
IPO DateJul 28, 2022
IndustryBiotechnology
SectorHealthcare
Employees13
CEOVlad Vitoc

Contact Details

Address:
444 West Lake Street, Suite 1700
Chicago, Illinois 60606
United States
Phone312 416 8592
Websitemaiabiotech.com

Stock Details

Ticker SymbolMAIA
ExchangeNYSEAMERICAN
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$5.00
CIK Code1878313
CUSIP Number552641102
ISIN NumberUS5526411021
SIC Code2834

Key Executives

NamePosition
Dr. Vlad Vitoc M.B.A., M.D.Co-Founder, President, Chief Executive Officer and Chairman of the Board of Directors
Jeffrey C. HimmelreichHead of Finance and Principal Financial and Accounting Officer
Dr. Sergei M. Gryaznov Ph.D.Chief Scientific Officer
Linda MoreiraCompany Secretary

Latest SEC Filings

DateTypeTitle
Dec 17, 20258-KCurrent Report
Dec 11, 20258-KCurrent Report
Dec 10, 20258-KCurrent Report
Dec 4, 2025SCHEDULE 13D/AFiling
Nov 21, 20258-KCurrent Report
Nov 20, 20258-KCurrent Report
Nov 7, 202510-QQuarterly Report
Nov 7, 20258-KCurrent Report
Oct 27, 20258-KCurrent Report
Oct 24, 20258-KCurrent Report
View All SEC Filings